🏛️ Verified NIH Record • Updated 2025-12-03
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study (NCT00616317)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University of California, Davis
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Who can join: Review the eligibility criteria below.
Location: UC Davis Medical Center — Sacramento, California
Age range: 1 Minute to 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UC Davis Medical Center — Sacramento, California
📞 Contact the Study Coordinator
Phone: (916) 734-8118
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Antiphospholipid Syndrome
- Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome — Durham, North Carolina
- Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS — Buenos Aires, Buenos Aires F.D.
Explore by condition: All Antiphospholipid Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.